Luff Enterprises Ltd.
CA$0.01+CA$0.01 (+100.0%)
Luff Enterprises Ltd.: Healthcare · Drug Manufacturers - Specialty & Generic.
CNQ · RMC.CN · CAD
Stock price, earnings
Quote as of Mar 18, 2024, 02:20 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Refined Metals Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Refined Metals Corp. is an early-stage enterprise dedicated to sourcing, investigating, and developing mineral prospects. The company, which was formerly known as Chemesis International Inc., officially adopted its current name in November 2022. Its operational base is situated in Vancouver, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:09 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
CA$0.01+CA$0.01 (+100.0%)
Luff Enterprises Ltd.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.01-CA$0.01 (-33.33%)
Filament Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 85.71% below the high.
CA$0.02CA$0.00 (0.0%)
ManifestSeven Holdings Corporation: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.36CA$0.00 (0.0%)
Acerus Pharmaceuticals Corporation’s quoted price sits in the lower half of its reported 52-week range, 96.4% below the high.
CA$0.05CA$0.00 (0.0%)
Craftport Cannabis Corp.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.01$0.00 (0.0%)
MYND Life Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.0% below the high.
$0.00$0.00 (0.0%)
THC Biomed Intl Ltd.’s quoted price sits in the lower half of its reported 52-week range, 95.92% below the high.
$0.00$0.00 (0.0%)
Body and Mind Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.0% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.